<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8709538</journal-id>
<journal-id journal-id-type="pubmed-jr-id">5861</journal-id>
<journal-id journal-id-type="nlm-ta">Neurotoxicol Teratol</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurotoxicol Teratol</journal-id>
<journal-title-group>
<journal-title>Neurotoxicology and teratology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0892-0362</issn>
<issn pub-type="epub">1872-9738</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29408446</article-id>
<article-id pub-id-type="pmc">6093803</article-id>
<article-id pub-id-type="doi">10.1016/j.ntt.2018.01.009</article-id>
<article-id pub-id-type="manuscript">NIHMS970459</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Prenatal substance exposure and offspring development: Does DNA methylation play a role?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Knopik</surname>
<given-names>Valerie S.</given-names>
</name>
<!--<email>vknopik@purdue.edu</email>-->
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marceau</surname>
<given-names>Kristine</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bidwell</surname>
<given-names>L. Cinnamon</given-names>
</name>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rolan</surname>
<given-names>Emily</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>Department of Human Development and Family Studies, Purdue University, West Lafayette, IN, USA</aff>
<aff id="A2">
<label>b</label>Institute of Cognitive Science, University of Colorado, Boulder, CO, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding author at: Department of Human Development and Family Studies, Purdue University, Fowler Memorial House, 1200 West State Street, West Lafayette, IN 47907-2055, USA</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>25</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>16</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<season>Jan-Feb</season>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>71</volume>
<fpage>50</fpage>
<lpage>63</lpage>
<!--elocation-id from pubmed: 10.1016/j.ntt.2018.01.009-->
<abstract>
<p id="P1">The period of in utero development is one of the most critical windows during which adverse conditions and exposures may influence the growth and development of the fetus as well as its future postnatal health and behavior. Maternal substance use during pregnancy remains a relatively common but nonetheless hazardous in utero exposure. For example, previous epidemiological studies have associated prenatal substance exposure with reduced birth weight, poor developmental and psychological outcomes, and increased risk for diseases and behavioral disorders (e.g., externalizing behaviors like ADHD, conduct disorder, and substance use) later in life. Researchers are now learning that many of the mechanisms whereby adverse in utero exposures may affect key pathways crucial for proper fetal growth and development are epigenetic in nature, with the majority of work in humans considering DNA methylation specifically. This review will explore the research to date on epigenetic alterations tied to maternal substance use during pregnancy and will also discuss the possible role of DNA methylation in the robust relationship between maternal substance use and later behavioral and developmental sequelae in offspring.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>